Results and discussion
Three distinct regions in HIV-1 Nef that contribute to CD4 downregulation have been identified: two disordered loops of unknown function located at amino acids 2-39 and 148-180, and a potential CD4-binding site formed by two discontinuous sequences within the core structure of Nef [7] [8] [9] . In HIV-1 NL4-3 Nef, a highly conserved dileucine motif is located at residues 164-165 in the second disordered loop. This motif shares properties associated with other dileucine-based internalization signals, including an upstream acidic residue [10] and a proximal proline residue (at positions 160 and 167, respectively, in NL4-3 Nef) potentially associated with a β-turn structure [11] .
To determine whether this dileucine motif and flanking sequences in HIV-1 Nef function in CD4 downregulation, we used NL4-3 Nef mutants in which these amino acids were replaced with alanine residues: Nef L164A/L165A (Nef LL/AA), Nef E160A and Nef P167A (in the singleletter amino-acid code). Using flow cytometry to quantitate cell-surface expression of CD4 on human 293 cells, we observed that the Nef LL/AA mutant was impaired for CD4 downregulation compared with wild-type Nef ( Figure 1) . Similarly, mutation of comparable leucines in the SF2 allele of Nef inhibited CD4 downregulation (data not shown). The E160A and P167A mutations did not disable Nef for CD4 downregulation, but a composite R35A/D36A/D174A/D175A mutant (altered at amino acids in the two disordered loops) failed to downregulate CD4. Thus, in addition to other structural elements, HIV-1 Nef requires a conserved dileucine motif (at residues 164-165 of NL4-3 Nef) to downregulate CD4.
The role of the dileucine motif in Nef in directing intracellular protein traffic was further evaluated by preparing a chimera composed of the extracellular and transmembrane domains of human CD8 and a cytoplasmic tail of either wild-type Nef or Nef LL/AA sequences. Such chimeras have served as valuable tools for examining internalization signals within Nef [3, 12] . By flow cytometry, the percentage of CD8-Nef LL/AA transfected cells bearing cell-surface CD8 was approximately four times greater than for cells transfected with CD8-Nef (wild-type), and was comparable to the cellsurface expression of CD8 in cells transfected with CD8 alone (Figure 2a ). These findings suggest that the CD8-Nef LL/AA mutant is preferentially expressed at the cell surface compared with CD8-Nef. Analysis of whole-cell lysates demonstrated equivalent amounts of CD8-Nef and CD8-Nef LL/AA at steady-state expression (Figure 2c ).
The decrease in cell-surface expression of CD8-Nef relative to CD8-Nef LL/AA could reflect either retention of the chimera in the biosynthetic pathway or enhanced endocytosis from the cell surface. To investigate whether the dileucine sequence has a role in the rate of endocytosis, we compared the rates of internalization of CD8-Nef and CD8-Nef LL/AA chimeras (Figure 2b ). CD8-Nef was internalized nearly four times more rapidly than CD8-Nef LL/AA. These results support the notion that the dileucine motif serves as an internalization signal and that the enhanced surface expression of CD8-Nef LL/AA derives at least in part from its diminished rate of endocytosis.
To determine whether the dileucine motif in Nef is sufficient to stimulate endocytosis, we created a chimeric protein composed of the IL-2 receptor α chain (IL-2Rα) fused at its cytoplasmic carboxyl terminus to an 11-aminoacid segment (GENTSLLHPVS) of HIV-1 Nef containing the dileucine motif (IL-2Rα-LL) or lacking it (IL-2Rα-AA). The IL-2Rα protein has a short cytoplasmic tail of 13 amino acids which lacks an internalization signal and it is not efficiently endocytosed via clathrincoated pits. Using flow cytometry to measure the rate of internalization [3] , we found that IL-2Rα-LL was internalized nearly five times faster than IL-2Rα-AA ( Figure  3 ). These results demonstrate that the 11-amino-acid segment of Nef spanning the dileucine motif forms an effective internalization signal when presented on the cytoplasmic tail of a chimeric transmembrane protein.
We next investigated whether HIV-1 Nef physically interacts with components of the endocytic machinery via this dileucine motif. HeLa cell lysates were incubated with a series of glutathione-S-transferase (Figure 4a ). In contrast, Nef R35A/D36A/D174A/D175A, which fails to downregulate CD4, effectively bound to AP-1, suggesting that its defect is distinct from that in the Nef LL/AA mutant. AP-1 also bound to the Nef E160A and Nef P167A mutants, although the E160A mutant consistently captured less AP-1. To ensure that the dileucine mutant of Nef did not disrupt its overall structure, we tested the ability of Nef LL/AA to bind p59 Hck . The p59 Hck protein interacts with Nef at the proline-rich SH3-ligand domain situated at amino acids 69-73 [13] . Notably, the Nef LL/AA continued to bind p59 Hck , indicating that the dileucine substitution did not cause a gross change in conformation (Figure 4a) . Together, these studies demonstrate that HIV-1 Nef physically interacts with the AP-1 adaptor complex in vitro in a dileucinedependent manner.
We were unable to detect similar binding of HIV-1 Nef to AP-2 under comparable conditions. In this regard, others have also failed to detect an interaction between HIV-1 Nef and AP-2 by the yeast two-hybrid method or by immunoprecipitation under physiological salt conditions [4, 5, 14] . However, a fusion protein composed of HIV-1 Nef and green fluorescent protein (GFP) colocalizes with AP-2 at the plasma membrane [15] . We suspect that our failure to detect AP-2 binding is due to a lower affinity of Nef for this adaptor than for AP-1.
To establish whether AP-1 physically interacts with Nef in vivo, we transiently expressed the CD8-Nef or CD8-Nef LL/AA proteins in human 293 cells and immunoprecipitated the fusion proteins with anti-CD8 antibodies. Subsequent detection of AP-1 confirmed that this adaptor co-immunoprecipitated with the CD8-Nef protein but not with CD8-Nef LL/AA or with native CD8 (Figure 4b ). Binding of AP-2 with CD8-Nef was not detected under these conditions. These findings demonstrate the in vivo association of HIV-1 Nef with the AP-1 clathrin adaptor.
In the trans-Golgi network, AP-1 recruits clathrin to form vesicles that transit to a recycling endosome compartment for further sorting to the plasma membrane or to lysosomes or for return to the Golgi (reviewed in [16] ). Sorting of host proteins in the endosomal compartment involves the
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Figure 3
Internalization of IL-2Rα chimeras in human 293 cells. An 11-aminoacid segment (GENTSLLHPVS) of HIV-1 Nef containing the dileucine motif and flanking residues (designated IL-2Rα-LL), or the same peptide with alanines substituted for the leucines (IL-2Rα-AA), was fused to IL-2Rα. Assays were conducted as described in Figure 2b , except that the cells were stained with anti-CD25-RPE (Caltag).
IL-2Rα
Current vesicle coat proteins, although the molecular mechanism is not clearly understood. The physical association of HIV Nef with AP-1 may serve to redirect sorting and exit of host proteins, such as CD4 and MHC class I molecules, from the Golgi or from endosomes. In the presence of Nef, CD4 is redistributed to lysosomes [17, 18] and is also disrupted in transit from the Golgi to the plasma membrane [1, 3] .
Several biological functions, in addition to downregulation of cell-surface CD4 and MHC class I molecules, have been attributed to Nef. For example, HIV-1 Nef enhances the infectivity of HIV virions [19, 20] , modulates receptor signaling through the T-cell receptor complex (reviewed in [21] ) and expands the lysosomal and endosomal compartments within the cell [22] . The biochemical basis for these diverse functions remains unknown. It is interesting to consider the possibility that these various Nef functions may result from interactions with AP-1 and possibly other cellular adaptors, which are regulated by phosphorylation events. Consistent with its association with various cellular kinases, Nef may mediate the phosphorylation of regulatory proteins in the cell-sorting machinery. Such a model could provide a unifying explanation for Nef's diverse effects on cellular physiology.
In contrast to the tyrosine motifs present in the HIV-2 and SIV Nefs, the dileucine motif is highly conserved in all HIV-1 alleles and, despite strong evolutionary pressure, a corresponding leucine motif is also well conserved among some HIV-2 and SIV alleles. Conservation of this leucine motif suggests that it represents a key structural determinant of Nef function. As HIV-1 and HIV-2/SIV have evolved different strategies to interact with the cellular adaptors underlying CD4 and MHC class I downregulation, it will be of interest to determine whether the dileucine motif exerts functional effects in the HIV-2/SIV system. During the review of this manuscript, Craig and colleagues [23] described similar findings regarding the dileucine motif in HIV-1 and its function as an internalization signal.
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Additional methodological detail is published with this paper on the internet.
A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor 
Supplementary materials and methods
Monoclonal antibody 100/3, specific for the γ subunit of AP-1 (Sigma), was used at a dilution of 1:500 for immunoblotting. OKT8 antibody specific for the human CD8 antigen was obtained from A. Weiss (UCSF, San Francisco). For fluorescence-activated cell sorting (FACS) analysis of cell-surface receptors, anti-CD4-FITC, anti-CD4-PE, anti-CD8-PE and anti-CD8-FITC were obtained from Becton Dickinson. Anti-Hck monoclonal antibody was obtained from Transduction Laboratories. Anti-CD25-PE and anti-CD25-TC were obtained from Caltag. Rabbit antiserum GF7 was generated to HIV-1 R7/3 Nef using a recombinant Nef as the immunogen.
GST-Nef fusion proteins were expressed in the BL21 strain of Escherichia coli using the pGEX2T vector (Pharmacia) and isolated on glutathione-Sepharose 4B beads (Pharmacia). HeLa cell lysates were prepared in lysis buffer (1% NP-40, 150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 1 mM PMSF, 1× protease inhibitor cocktail (Boehringer Mannheim)). For binding of p59 Hck , 293 cells were transfected with plasmid LNCX HCK p59 [S1], then harvested after 40 h as described [13] .
The plasmid pNL4-3 Nef HA was prepared by subcloning NL4-3 Nef into the vector pCMV4neo [S2] . Site-directed mutants of both pNL4-3 Nef HA and pCN were created using the Bio-Rad Mutagene Kit (BioRad). The plasmid pCD8 contains human CD8 in the pCMV4 vector [S2] and the plasmid pCN contains a CD8-SF2 Nef fusion protein [12] . Wild-type or mutant NL4-3 nef genes were amplified by PCR and inserted into pCN.
The cDNAs for the IL-2Rα-Nef 159-169 chimeras were prepared by PCR of the IL-2Rα cDNA with DNA primers which extended the IL-2Rα cDNA sequences to encode an additional 11 carboxy-terminal amino acids, GENTSL 164 L 165 HPVS or GENTSA 164 A 165 HPVS, at the carboxyl terminus. The plasmids pIL-2Rα-Nef 159-169 and pIL-2Rα-Nef 159-169(LL164/165AA) were made by inserting these PCR products into the pCMV4 vector. All constructs were verified by DNA sequencing.
